EP1955709 - Adjuvant compositions for enhancing immune responses to polynucleotide-based vaccines [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 18.01.2013 Database last updated on 09.09.2024 | Most recent event Tooltip | 30.05.2014 | Lapse of the patent in a contracting state New state(s): LU | published on 02.07.2014 [2014/27] | Applicant(s) | For all designated states VICAL INCORPORATED 10390 Pacific Center Court San Diego, California 92121-4343 / US | [2008/33] | Inventor(s) | 01 /
Wheeler, Carl J. 14101 Arbolitos Drive Poway, CA 92064 / US | [2008/33] | Representative(s) | Walton, Seán Malcolm, et al Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [N/P] |
Former [2012/11] | Walton, Seán Malcolm, et al Mewburn Ellis LLP 33 Gutter Lane London EC2V 8AS / GB | ||
Former [2008/33] | Walton, Seán Malcolm, et al Mewburn Ellis LLP York House 23 Kingsway London WC2B 6HP / GB | Application number, filing date | 08006254.0 | 24.03.2000 | [2008/33] | Priority number, date | US19990126340P | 26.03.1999 Original published format: US 126340 P | [2008/33] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP1955709 | Date: | 13.08.2008 | Language: | EN | [2008/33] | Type: | A3 Search report | No.: | EP1955709 | Date: | 20.08.2008 | [2008/34] | Type: | B1 Patent specification | No.: | EP1955709 | Date: | 14.03.2012 | Language: | EN | [2012/11] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 18.07.2008 | Classification | IPC: | A61K39/39, A61K9/127 | [2011/39] | CPC: |
A61K39/39 (EP,US);
A61K31/7088 (EP,US);
A61K47/6911 (EP,US);
A61K9/1272 (EP,US);
A61P31/00 (EP);
A61P31/04 (EP);
A61P31/12 (EP);
A61P33/00 (EP);
A61P35/00 (EP);
A61P37/04 (EP);
A61P37/08 (EP);
A61K2039/53 (EP,US);
A61K2039/55511 (EP,US);
A61K2039/57 (EP,US);
Y02A50/30 (EP,US);
Y10S977/802 (EP,US)
(-)
| C-Set: |
A61K31/7088, A61K2300/00 (EP,US)
|
Former IPC [2008/33] | A61K47/18, A61K39/39, A61P31/04, A61P31/12, A61P33/00, A61P35/00, C07C217/28, // A61P33/00, A61P35/00, C07C217/28 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2008/33] | Title | German: | Adjuvanzverbindungen zur Verbesserung von Immunreaktionen auf Polynukleotid-basierten Impfstoffen | [2008/33] | English: | Adjuvant compositions for enhancing immune responses to polynucleotide-based vaccines | [2008/33] | French: | Compositions d'adjuvant d'amélioration des réponses immunitaires aux vaccins à base de polynucléotide | [2008/33] | Examination procedure | 31.03.2008 | Examination requested [2008/33] | 11.03.2009 | Despatch of a communication from the examining division (Time limit: M06) | 29.10.2009 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 06.01.2010 | Reply to a communication from the examining division | 02.07.2010 | Despatch of a communication from the examining division (Time limit: M04) | 14.09.2010 | Reply to a communication from the examining division | 27.10.2011 | Communication of intention to grant the patent | 31.01.2012 | Fee for grant paid | 31.01.2012 | Fee for publishing/printing paid | Parent application(s) Tooltip | EP00919777.3 / EP1165140 | EP04014973.4 / EP1459766 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20000919777) is 04.03.2003 | Opposition(s) | 17.12.2012 | No opposition filed within time limit [2013/08] | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 06.01.2010 | Request for further processing filed | 06.01.2010 | Full payment received (date of receipt of payment) Request granted | 20.01.2010 | Decision despatched | Fees paid | Renewal fee | 31.03.2008 | Renewal fee patent year 03 | 31.03.2008 | Renewal fee patent year 04 | 31.03.2008 | Renewal fee patent year 05 | 31.03.2008 | Renewal fee patent year 06 | 31.03.2008 | Renewal fee patent year 07 | 31.03.2008 | Renewal fee patent year 08 | 31.03.2008 | Renewal fee patent year 09 | 26.03.2009 | Renewal fee patent year 10 | 08.03.2010 | Renewal fee patent year 11 | 10.03.2011 | Renewal fee patent year 12 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 14.03.2012 | BE | 14.03.2012 | CY | 14.03.2012 | DK | 14.03.2012 | FI | 14.03.2012 | IT | 14.03.2012 | NL | 14.03.2012 | SE | 14.03.2012 | IE | 24.03.2012 | LU | 24.03.2012 | MC | 31.03.2012 | GR | 15.06.2012 | ES | 25.06.2012 | PT | 16.07.2012 | [2014/27] |
Former [2013/22] | AT | 14.03.2012 | |
BE | 14.03.2012 | ||
CY | 14.03.2012 | ||
DK | 14.03.2012 | ||
FI | 14.03.2012 | ||
IT | 14.03.2012 | ||
NL | 14.03.2012 | ||
SE | 14.03.2012 | ||
IE | 24.03.2012 | ||
MC | 31.03.2012 | ||
GR | 15.06.2012 | ||
ES | 25.06.2012 | ||
PT | 16.07.2012 | ||
Former [2013/11] | AT | 14.03.2012 | |
BE | 14.03.2012 | ||
CY | 14.03.2012 | ||
DK | 14.03.2012 | ||
FI | 14.03.2012 | ||
IT | 14.03.2012 | ||
NL | 14.03.2012 | ||
SE | 14.03.2012 | ||
IE | 24.03.2012 | ||
MC | 31.03.2012 | ||
GR | 15.06.2012 | ||
PT | 16.07.2012 | ||
Former [2013/08] | AT | 14.03.2012 | |
BE | 14.03.2012 | ||
CY | 14.03.2012 | ||
DK | 14.03.2012 | ||
FI | 14.03.2012 | ||
NL | 14.03.2012 | ||
SE | 14.03.2012 | ||
IE | 24.03.2012 | ||
MC | 31.03.2012 | ||
GR | 15.06.2012 | ||
PT | 16.07.2012 | ||
Former [2013/07] | AT | 14.03.2012 | |
BE | 14.03.2012 | ||
CY | 14.03.2012 | ||
FI | 14.03.2012 | ||
SE | 14.03.2012 | ||
MC | 31.03.2012 | ||
GR | 15.06.2012 | ||
PT | 16.07.2012 | ||
Former [2013/01] | BE | 14.03.2012 | |
CY | 14.03.2012 | ||
FI | 14.03.2012 | ||
SE | 14.03.2012 | ||
MC | 31.03.2012 | ||
GR | 15.06.2012 | ||
PT | 16.07.2012 | ||
Former [2012/48] | BE | 14.03.2012 | |
CY | 14.03.2012 | ||
FI | 14.03.2012 | ||
SE | 14.03.2012 | ||
MC | 31.03.2012 | ||
GR | 15.06.2012 | ||
Former [2012/47] | BE | 14.03.2012 | |
CY | 14.03.2012 | ||
FI | 14.03.2012 | ||
MC | 31.03.2012 | ||
GR | 15.06.2012 | ||
Former [2012/46] | BE | 14.03.2012 | |
CY | 14.03.2012 | ||
FI | 14.03.2012 | ||
GR | 15.06.2012 | ||
Former [2012/41] | CY | 14.03.2012 | |
FI | 14.03.2012 | ||
GR | 15.06.2012 | ||
Former [2012/37] | FI | 14.03.2012 | |
GR | 15.06.2012 | ||
Former [2012/36] | GR | 15.06.2012 | Documents cited: | Search | [A]WO9719675 (VICAL INC [US]) [A] 1-41 * the whole document *; | [A] - NORMAN J A ET AL, "Development of improved vectors for DNA-based immunization and other gene therapy applications", VACCINE, (19970601), vol. 15, no. 8, pages 801 - 803, XP004075655 [A] 1-41 * the whole document * DOI: http://dx.doi.org/10.1016/S0264-410X(96)00247-2 | [A] - WHEELER C J ET AL, "CONVERTING AN ALCOHOL TO AN AMINE IN A CATIONIC LIPID DRAMATICALLY ALTERS TO CO-LIPID REQUIREMENT, CELLULAR TRANSFECTION ACTIVITY AND THE ULTRASTRUCTURE OF DNA-CYTOFECTIN COMPLEXES", BIOCHIM BIOPHYS ACTA, (1996), vol. 1280, no. 1, pages 1 - 11, XP002035803 [A] 1-41 * the whole document * DOI: http://dx.doi.org/10.1016/0005-2736(95)00256-1 | [DA] - WHEELER C J ET AL, "A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung.", PROC NAT ACAD SCI USA, 1996, (1996), vol. 93, no. 21, pages 11454 - 11459, XP002150135 [DA] 1-41 * the whole document * DOI: http://dx.doi.org/10.1073/pnas.93.21.11454 | by applicant | US5264618 | WO9429469 | US5580859 | US5589466 | US5676954 | US5693622 | US5703055 | - FEIGNER, SCIENTIFIC AMERICAN, (1997), vol. 276, no. 6, pages 102 - 106 | - FELGNER ET AL., NATURE, (1991), vol. 349, pages 351 - 352 | - ULMER ET AL., CURRENT OPINIONS IN IMMUNOLOGY, (1996), vol. 8, pages 531 - 536 | - BOYER ET AL., J. MED. PRIMATOLOGY, (1996), vol. 25, no. 3, pages 242 - 250 | - BOYER ET AL., NATURE MEDICINE, (1997), vol. 3, no. 5, pages 526 - 532 | - DAVIS ET AL., VACCINE, (1997), vol. 15, no. 8, pages 849 - 852 | - WANG ET AL., VACCINE, (1997), vol. 15, no. 8, pages 821 - 825 | - AGADJANYAN ET AL., CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY, (1998), vol. 226, pages 175 - 192 | - HEPPELL ET AL., FISH & SHEDLFISH IMMUNOLOGY, (1998), vol. 8, no. 4, pages 271 - 286 | - LODMELL ET AL., NATURE MEDICINE, (1998), vol. 4, no. 8, pages 949 - 952 | - VANDERZANDEN ET AL., VIROLOGY, (1998), vol. 246, no. 1, pages 134 - 144 | - SASAKI, S. ET AL., INFECTION AND IMMUNITY, (1997), vol. 65, no. 9, pages 3250 - 3258 | - SASAKI, S. ET AL., CLIN, EXP. IMMUNOL., (1998), vol. 111, pages 30 - 35 | - SASAKI, S. ET AL., J. VIROLOGY, (1998), vol. 72, no. 6, pages 4391 - 4939 | - ISHII, N. ET AL., AIDS RES. HUM, RETROVIRUSES, (1997), vol. 13, no. 16, pages 1421 - 1428 | - OKADA, E. ET AL., J. IMMUNOLOGY, (1997), vol. 159, pages 3638 - 3647 | - YOKOYAMA, M. ET AL., FEMS IMMUNOL. MED. MICROBIOL., (1996), vol. 14, pages 221 - 230 | - GREGORIADIS, G. ET AL., FEBS LETTERS, (1997), vol. 402, pages 107 - 110 | - GRAMZINSKI, R.A. ET AL., MOLECULAR MEDICINE, (1998), vol. 4, pages 109 - 118 | - KLAVINSKIS, L.S. ET AL., VACCINE, (1997), vol. 15, no. 8, pages 818 - 820 | - KLAVINSKIS, L.S. ET AL., J. IMMUNOLOGY, (1999), vol. 162, pages 254 - 262 | - ETCHART, N. ET AL., J. GEN. VIROLOGY, (1997), vol. 78, pages 1577 - 1580 | - "Methods in Molecular Medicine", NORMAN, J. ET AL., DNA Vaccines: Methods and Protocols, (1999), vol. 9, pages 185 - 196 | - DNA Vaccines: Methods and Protocols, (1999), vol. 16, pages 185 - 196 | - STEPHAN, D.J. ET AL., HUMAN GENE THERAPY, (1996), vol. 7, pages 1803 - 1812 | - DEBRUYNE, L.A. ET AL., GENE THERAPY, (1998), vol. 5, pages 1079 - 1087 | - FELGNER ET AL., PROC. NATL. ACAD. SCI. USA, (1987), vol. 84, pages 7413 - 7417 | - VAHLSING, H. ET AL., J. IMMUNOL. METHODS, (1994), vol. 171, pages 11 - 22 | - SCHRIJVER, R. ET AL., VACCINE, (1997), vol. 15, pages 1908 - 1916 | - DAVIS, H ET AL., VACCINE, (1994), vol. 12, pages 1503 - 1509 | - GRAMZINSKI, R. ET AL., MOL. MED, (1998), vol. 4, pages 109 - 118 | - QIN ET AL., LIFE SCIENCES, (1999), vol. 65, pages 2193 - 2203 | - WHEELER ET AL., PROC. NATL. ACAD. SCI., (1996), vol. 93, pages 11454 - 11459 | - HARTIKKA, J. ET AL., HUMAN GENE THERAPY, (1996), vol. 7, pages 1205 - 1217 | - VAHLSING, L ET AL., J. IMMUNOL. METHODS, (1994), vol. 174, pages 11 - 22 | - DOH, S,G. ET AL., GENE THERAPY, (1997), vol. 4, no. 7, pages 268 - 263 | - HARTIKKA, J. ET AL., HUMAN GENE THERAPY, (1996), vol. 7, no. 10, pages 1205 - 17 | - HARTIKKA, J. ET AL., HUMAN GENE THERAPY, (1996), vol. 7, pages 1205 - 17 | - HORN, N.A. ET AL., HUMAN GENE THERAPY, (1995), vol. 6, pages 565 - 573 | - ULMER ET AL., SCIENCE, (1993), vol. 259, pages 1745 - 1749 | - SLIFKA, M.K. ET AL., J. VIROL., (1995), vol. 69, no. 3, pages 1895 - 1902 | - SLIFKA, M.K., J. VIROL., (1995), vol. 69, no. 3, pages 1895 - 1902 | - SLIFKA, M.K. ET AL., CURRO OPIN. IMMUNOL, (1998), vol. 10, no. 3, pages 252 - 258 | - HORTON, H.M ET AL., J IMMUNOL., (1999), vol. 163, no. 12, pages 6378 - 6385 | - DOW, S.W. ET AL., Î IMMUNOL., (1999), vol. 163, no. 3, pages 1552 - 1561 | - BEARD, C.W. ET AL., NAT. BIOTECHNOL, (1998), vol. 16, no. 13, pages 1325 - 1328 | - BEARD, C.W. ET AL., NAT. BIOTECHNOL, (1998), vol. 6, no. 13, pages 1325 - 1328 |